Sai Parenterals informs about board meeting

Pursuant to Regulation 29 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sai Parenterals has informed that the Board Meeting of the Company will be held on Sunday, 01st November, 2026 at the registered office of the Company to consider, the following: 1. Un-audited financial results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2026. 2. Limited Review Report (Standalone and Consolidated) for the quarter and half year ended 30th September, 2026. 3. Any other business with the permission of the Chair. Further, with reference to its letter dated 30th September, 2026 regarding closure of trading window for dealing in shares of the Company, the company has informed that, pursuant to the Code of Conduct to Regulate, Monitor and Report Trading in Securities of the Company, the trading window shall continue to remain closed for all Designated Persons of the Company and their Immediate Relatives until 48 hours after the declaration of the Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2026.

The above information is a part of company’s filings submitted to BSE.